XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.3
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]          
Intangible Assets, Gross (Excluding Goodwill) $ 5,443.5   $ 5,443.5   $ 5,058.4
Goodwill 6,482.4   6,482.4   6,142.5
Amortization of intangibles and other assets 63.7 $ 55.7 186.0 $ 160.6  
Adjustments to goodwill     (9.6)    
Estimated amortization expense, 2013 260.4   260.4    
Estimated amortization expense, 2014 251.4   251.4    
Estimated amortization expense, 2015 240.1   240.1    
Estimated amortization expense, 2016 232.2   232.2    
Estimated amortization expense, Thereafter 1,915.4   1,915.4    
Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings     7.7    
Amortization of intangible assets 63.7 $ 55.7 186.0 $ 160.6  
LabCorp Diagnostics [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 5,153.9   5,153.9   4,813.9
Adjustments to goodwill     (9.5)    
Covance Drug Development [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill $ 1,328.5   1,328.5   $ 1,328.6
Adjustments to goodwill     $ (0.1)